Twist Bioscience Corporation
TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital dā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$56.21
Price-1.13%
-$0.64
1Y
Price
Market Cap
$3.500b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-23.2%
EBITDA Margin-29.4%
Net Profit Margin-33.5%
Free Cash Flow Margin-23.2%
EBITDA Margin-29.4%
Net Profit Margin-33.5%
Free Cash Flow MarginRevenue
$409.479m
+4.0%
1y CAGR+17.3%
3y CAGR+18.1%
5y CAGREarnings
-$81.276m
+1.4%
1y CAGR+20.7%
3y CAGR+17.1%
5y CAGREPS
-$1.33
+1.5%
1y CAGR+21.8%
3y CAGR+19.1%
5y CAGRBook Value
$455.094m
$676.214m
Assets$221.120m
Liabilities$95.841m
DebtDebt to Assets
14.2%
-3.6x
Debt to EBITDAFree Cash Flow
-$95.140m
-14.7%
1y CAGR+11.8%
3y CAGR+15.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company